Assessing the causes and consequences of co-polymerization in amyloid formation

References

• Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fändrich M. Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol 2009; 386:869 - 77; http://dx.doi.org/10.1016/j.jmb.2008.11.005; PMID: 19038266
   PubMed Web of Science ®Google Scholar
• Eichner T, Radford SE. A diversity of assembly mechanisms of a generic amyloid fold. Mol Cell 2011; 43:8 - 18; http://dx.doi.org/10.1016/j.molcel.2011.05.012; PMID: 21726806
   PubMed Web of Science ®Google Scholar
• Fändrich M, Meinhardt J, Grigorieff N. Structural polymorphism of Alzheimer Abeta and other amyloid fibrils. Prion 2009; 3:89 - 93; http://dx.doi.org/10.4161/pri.3.2.8859; PMID: 19597329
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AW, Debelouchina GT, Bayro MJ, Clare DK, Caporini MA, Bajaj VS, Jaroniec CP, Wang L, Ladizhansky V, Müller SA, et al. Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc Natl Acad Sci U S A 2013; 110:5468 - 73; http://dx.doi.org/10.1073/pnas.1219476110; PMID: 23513222
   PubMed Web of Science ®Google Scholar
• Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJ, McFarlane HT, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007; 447:453 - 7; http://dx.doi.org/10.1038/nature05695; PMID: 17468747
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell 2012; 148:1188 - 203; http://dx.doi.org/10.1016/j.cell.2012.02.022; PMID: 22424229
   PubMed Web of Science ®Google Scholar
• Paschos A, Bauer A, Zimmermann A, Zehelein E, Böck A. HypF, a carbamoyl phosphate-converting enzyme involved in [NiFe] hydrogenase maturation. J Biol Chem 2002; 277:49945 - 51; http://dx.doi.org/10.1074/jbc.M204601200; PMID: 12377778
   PubMed Web of Science ®Google Scholar
• Campioni S, Mannini B, Zampagni M, Pensalfini A, Parrini C, Evangelisti E, Relini A, Stefani M, Dobson CM, Cecchi C, et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol 2010; 6:140 - 7; http://dx.doi.org/10.1038/nchembio.283; PMID: 20081829
   PubMed Web of Science ®Google Scholar
• Cremades N, Cohen SI, Deas E, Abramov AY, Chen AY, Orte A, Sandal M, Clarke RW, Dunne P, Aprile FA, et al. Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 2012; 149:1048 - 59; http://dx.doi.org/10.1016/j.cell.2012.03.037; PMID: 22632969
   PubMed Web of Science ®Google Scholar
• Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, et al. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer’s disease. J Neurochem 2005; 95:834 - 47; http://dx.doi.org/10.1111/j.1471-4159.2005.03407.x; PMID: 16135089
   PubMed Web of Science ®Google Scholar
• Bernstein SL, Dupuis NF, Lazo ND, Wyttenbach T, Condron MM, Bitan G, Teplow DB, Shea JE, Ruotolo BT, Robinson CV, et al. Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer’s disease. Nat Chem 2009; 1:326 - 31; http://dx.doi.org/10.1038/nchem.247; PMID: 20703363
   PubMed Web of Science ®Google Scholar
• Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A 2009; 106:14745 - 50; http://dx.doi.org/10.1073/pnas.0905127106; PMID: 19706468
   PubMed Web of Science ®Google Scholar
• McLaurin J, Yang DS, Yip CM, Fraser PE. Review: modulating factors in amyloid-beta fibril formation. J Struct Biol 2000; 130:259 - 70; http://dx.doi.org/10.1006/jsbi.2000.4289; PMID: 10940230
   PubMed Web of Science ®Google Scholar
• Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 24:329 - 32; http://dx.doi.org/10.1016/S0968-0004(99)01445-0; PMID: 10470028
   PubMed Web of Science ®Google Scholar
• Krebs MR, Morozova-Roche LA, Daniel K, Robinson CV, Dobson CM. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci 2004; 13:1933 - 8; http://dx.doi.org/10.1110/ps.04707004; PMID: 15215533
   PubMed Web of Science ®Google Scholar
• Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. A structural model for Alzheimer’s beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A 2002; 99:16742 - 7; http://dx.doi.org/10.1073/pnas.262663499; PMID: 12481027
   PubMed Web of Science ®Google Scholar
• O’Nuallain B, Williams AD, Westermark P, Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 2004; 279:17490 - 9; http://dx.doi.org/10.1074/jbc.M311300200; PMID: 14752113
   PubMed Web of Science ®Google Scholar
• Fung J, Frost D, Chakrabartty A, McLaurin J. Interaction of human and mouse Abeta peptides. J Neurochem 2004; 91:1398 - 403; http://dx.doi.org/10.1111/j.1471-4159.2004.02828.x; PMID: 15584916
   PubMed Web of Science ®Google Scholar
• Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Human and rodent sequence analogs of Alzheimer’s amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. Eur J Biochem 1991; 201:61 - 9; http://dx.doi.org/10.1111/j.1432-1033.1991.tb16256.x; PMID: 1915378
   PubMedGoogle Scholar
• Eichner T, Kalverda AP, Thompson GS, Homans SW, Radford SE. Conformational conversion during amyloid formation at atomic resolution. Mol Cell 2011; 41:161 - 72; http://dx.doi.org/10.1016/j.molcel.2010.11.028; PMID: 21255727
   PubMed Web of Science ®Google Scholar
• Miroy GJ, Lai Z, Lashuel HA, Peterson SA, Strang C, Kelly JW. Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc Natl Acad Sci U S A 1996; 93:15051 - 6; http://dx.doi.org/10.1073/pnas.93.26.15051; PMID: 8986762
   PubMed Web of Science ®Google Scholar
• Reixach N, Foss TR, Santelli E, Pascual J, Kelly JW, Buxbaum JN. Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins. J Biol Chem 2008; 283:2098 - 107; http://dx.doi.org/10.1074/jbc.M708028200; PMID: 18006495
   PubMed Web of Science ®Google Scholar
• Hammarström P, Schneider F, Kelly JW. Trans-suppression of misfolding in an amyloid disease. Science 2001; 293:2459 - 62; http://dx.doi.org/10.1126/science.1062245; PMID: 11577236
   PubMed Web of Science ®Google Scholar
• Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Acc Chem Res 2005; 38:911 - 21; http://dx.doi.org/10.1021/ar020073i; PMID: 16359163
   PubMed Web of Science ®Google Scholar
• Jahn TR, Parker MJ, Homans SW, Radford SE. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol 2006; 13:195 - 201; http://dx.doi.org/10.1038/nsmb1058; PMID: 16491092
   PubMed Web of Science ®Google Scholar
• Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 1996; 383:685 - 90; http://dx.doi.org/10.1038/383685a0; PMID: 8878476
   PubMed Web of Science ®Google Scholar
• Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 1985; 129:701 - 6; http://dx.doi.org/10.1016/0006-291X(85)91948-5; PMID: 3893430
   PubMed Web of Science ®Google Scholar
• Calabrese MF, Eakin CM, Wang JM, Miranker AD. A regulatable switch mediates self-association in an immunoglobulin fold. Nat Struct Mol Biol 2008; 15:965 - 71; http://dx.doi.org/10.1038/nsmb.1483; PMID: 19172750
   PubMed Web of Science ®Google Scholar
• Platt GW, Radford SE. Glimpses of the molecular mechanisms of beta2-microglobulin fibril formation in vitro: aggregation on a complex energy landscape. FEBS Lett 2009; 583:2623 - 9; http://dx.doi.org/10.1016/j.febslet.2009.05.005; PMID: 19433089
   PubMed Web of Science ®Google Scholar
• Sarell CJ, Woods LA, Su Y, Debelouchina GT, Ashcroft AE, Griffin RG, Stockley PG, Radford SE. Expanding the repertoire of amyloid polymorphs by co-polymerization of related protein precursors. J Biol Chem 2013; 288:7327 - 37; http://dx.doi.org/10.1074/jbc.M112.447524; PMID: 23329840
   PubMed Web of Science ®Google Scholar
• Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer’s beta-amyloid fibrils. Science 2005; 307:262 - 5; http://dx.doi.org/10.1126/science.1105850; PMID: 15653506
   PubMed Web of Science ®Google Scholar
• Lashuel HA, Hartley DM, Petre BM, Wall JS, Simon MN, Walz T, Lansbury PT Jr.. Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J Mol Biol 2003; 332:795 - 808; http://dx.doi.org/10.1016/S0022-2836(03)00927-6; PMID: 12972252
   PubMed Web of Science ®Google Scholar
• Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VMY. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003; 300:636 - 40; http://dx.doi.org/10.1126/science.1082324; PMID: 12714745
   PubMed Web of Science ®Google Scholar
• Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer’s disease and Parkinson’s disease. Proc Natl Acad Sci U S A 2001; 98:12245 - 50; http://dx.doi.org/10.1073/pnas.211412398; PMID: 11572944
   PubMed Web of Science ®Google Scholar
• Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ. Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 1994; 51:888 - 95; http://dx.doi.org/10.1001/archneur.1994.00540210060013; PMID: 8080388
   PubMed Web of Science ®Google Scholar
• Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, et al. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer’s and Parkinson’s diseases. PLoS One 2008; 3:e3135; http://dx.doi.org/10.1371/journal.pone.0003135; PMID: 18769546
   PubMed Web of Science ®Google Scholar
• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519 - 50; http://dx.doi.org/10.1146/annurev.neuro.24.1.519; PMID: 11283320
   PubMed Web of Science ®Google Scholar
• Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P. The same prion strain causes vCJD and BSE. Nature 1997; 389:448 - 50, 526; http://dx.doi.org/10.1038/38925; PMID: 9333232
   PubMed Web of Science ®Google Scholar
• Makarava N, Ostapchenko VG, Savtchenko R, Baskakov IV. Conformational switching within individual amyloid fibrils. J Biol Chem 2009; 284:14386 - 95; http://dx.doi.org/10.1074/jbc.M900533200; PMID: 19329794
   PubMed Web of Science ®Google Scholar
• Makarava N, Baskakov IV. The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem 2008; 283:15988 - 96; http://dx.doi.org/10.1074/jbc.M800562200; PMID: 18400757
   PubMed Web of Science ®Google Scholar
• Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW. Interactions among prions and prion “strains” in yeast. Proc Natl Acad Sci U S A 2002; 99:Suppl 4 16392 - 9; http://dx.doi.org/10.1073/pnas.152330699; PMID: 12149514
   PubMed Web of Science ®Google Scholar
• Pauwels K, Williams TL, Morris KL, Jonckheere W, Vandersteen A, Kelly G, Schymkowitz J, Rousseau F, Pastore A, Serpell LC, et al. Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease. J Biol Chem 2012; 287:5650 - 60; http://dx.doi.org/10.1074/jbc.M111.264473; PMID: 22157754
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Younan ND, Sarell CJ, Davies P, Brown DR, Viles JH. The cellular prion protein traps Alzheimer’s Aβ in an oligomeric form and disassembles amyloid fibers. FASEB J 2013; 27:1847 - 58; http://dx.doi.org/10.1096/fj.12-222588; PMID: 23335053
   PubMed Web of Science ®Google Scholar
• MacPhee CE, Dobson CM. Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures. J Am Chem Soc 2000; 122:12707 - 13; http://dx.doi.org/10.1021/ja0029580
   Web of Science ®Google Scholar
• Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr., Eckman C, Golde TE, Younkin SG. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 1994; 264:1336 - 40; http://dx.doi.org/10.1126/science.8191290; PMID: 8191290
   PubMed Web of Science ®Google Scholar
• Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 1996; 2:864 - 70; http://dx.doi.org/10.1038/nm0896-864; PMID: 8705854
   PubMed Web of Science ®Google Scholar
• Janson J, Laedtke T, Parisi JE, O’Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004; 53:474 - 81; http://dx.doi.org/10.2337/diabetes.53.2.474; PMID: 14747300
   PubMed Web of Science ®Google Scholar
• Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufenbiel M, Levy E, Grubb A, Jucker M. Cystatin C modulates cerebral beta-amyloidosis. Nat Genet 2007; 39:1437 - 9; http://dx.doi.org/10.1038/ng.2007.23; PMID: 18026102
   PubMed Web of Science ®Google Scholar
• Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, et al. Cystatin C inhibits amyloid-beta deposition in Alzheimer’s disease mouse models. Nat Genet 2007; 39:1440 - 2; http://dx.doi.org/10.1038/ng.2007.29; PMID: 18026100
   PubMed Web of Science ®Google Scholar
• Li X, Masliah E, Reixach N, Buxbaum JN. Neuronal production of transthyretin in human and murine Alzheimer’s disease: is it protective?. J Neurosci 2011; 31:12483 - 90; http://dx.doi.org/10.1523/JNEUROSCI.2417-11.2011; PMID: 21880910
   PubMed Web of Science ®Google Scholar
• Fabbro S, Schaller K, Seeds NW. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer’s disease transgenic mouse model. J Neurochem 2011; 118:928 - 38; http://dx.doi.org/10.1111/j.1471-4159.2011.07359.x; PMID: 21689108
   PubMed Web of Science ®Google Scholar
• Jiménez JL, Nettleton EJ, Bouchard M, Robinson CV, Dobson CM, Saibil HR. The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci U S A 2002; 99:9196 - 201; http://dx.doi.org/10.1073/pnas.142459399; PMID: 12093917
   PubMed Web of Science ®Google Scholar
• Glabe CG. Structural classification of toxic amyloid oligomers. J Biol Chem 2008; 283:29639 - 43; http://dx.doi.org/10.1074/jbc.R800016200; PMID: 18723507
   PubMed Web of Science ®Google Scholar
• Gosal WS, Morten IJ, Hewitt EW, Smith DA, Thomson NH, Radford SE. Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J Mol Biol 2005; 351:850 - 64; http://dx.doi.org/10.1016/j.jmb.2005.06.040; PMID: 16024039
   PubMed Web of Science ®Google Scholar
• Xue WF, Hellewell AL, Hewitt EW, Radford SE. Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters. Prion 2010; 4:20 - 5; http://dx.doi.org/10.4161/pri.4.1.11378; PMID: 20305394
   PubMed Web of Science ®Google Scholar
• Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, et al. Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell 2013; 154:103 - 17; http://dx.doi.org/10.1016/j.cell.2013.05.057; PMID: 23827677
   PubMed Web of Science ®Google Scholar
• Chiou A, Hägglöf P, Orte A, Chen AY, Dunne PD, Belorgey D, Karlsson-Li S, Lomas DA, Klenerman D. Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence. Biophys J 2009; 97:2306 - 15; http://dx.doi.org/10.1016/j.bpj.2009.07.057; PMID: 19843463
   PubMed Web of Science ®Google Scholar
• Kinghorn KJ, Crowther DC, Sharp LK, Nerelius C, Davis RL, Chang HT, Green C, Gubb DC, Johansson J, Lomas DA. Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease. J Biol Chem 2006; 281:29268 - 77; http://dx.doi.org/10.1074/jbc.M600690200; PMID: 16849336
   PubMed Web of Science ®Google Scholar
• Ridgley DM, Ebanks KC, Barone JR. Peptide mixtures can self-assemble into large amyloid fibers of varying size and morphology. Biomacromolecules 2011; 12:3770 - 9; http://dx.doi.org/10.1021/bm201005k; PMID: 21879764
   PubMed Web of Science ®Google Scholar
• Jarrett JT, Berger EP, Lansbury PT Jr.. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Biochemistry 1993; 32:4693 - 7; http://dx.doi.org/10.1021/bi00069a001; PMID: 8490014
   PubMed Web of Science ®Google Scholar
• Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B, Hatami A, Rönicke R, et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature 2012; 485:651 - 5; http://dx.doi.org/10.1038/nature11060; PMID: 22660329
   PubMed Web of Science ®Google Scholar
• Ono K, Takahashi R, Ikeda T, Yamada M. Cross-seeding effects of amyloid β-protein and α-synuclein. J Neurochem 2012; 122:883 - 90; http://dx.doi.org/10.1111/j.1471-4159.2012.07847.x; PMID: 22734715
   PubMed Web of Science ®Google Scholar
• Willander H, Presto J, Askarieh G, Biverstål H, Frohm B, Knight SD, Johansson J, Linse S. BRICHOS domains efficiently delay fibrillation of amyloid β-peptide. J Biol Chem 2012; 287:31608 - 17; http://dx.doi.org/10.1074/jbc.M112.393157; PMID: 22801430
   PubMed Web of Science ®Google Scholar
• Yan LM, Velkova A, Tatarek-Nossol M, Andreetto E, Kapurniotu A. IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer’s disease and type II diabetes. Angew Chem Int Ed Engl 2007; 46:1246 - 52; http://dx.doi.org/10.1002/anie.200604056; PMID: 17203498
   PubMed Web of Science ®Google Scholar
• Nicoll AJ, Panico S, Freir DB, Wright D, Terry C, Risse E, Herron CE, O’Malley T, Wadsworth JD, Farrow MA, et al. Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity. Nat Commun 2013; 4:2416; http://dx.doi.org/10.1038/ncomms3416; PMID: 24022506
   PubMed Web of Science ®Google Scholar